Publisher: Bentham Science Publishers
E-ISSN: 1873-5592|6|5|559-566
ISSN: 1389-4501
Source: Current Drug Targets, Vol.6, Iss.5, 2005-08, pp. : 559-566
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Antithrombin III improves clinical and perinatal outcomes in pregnant women with pre-eclampsia
Inpharma, Vol. 1, Iss. 1262, 2000-01 ,pp. :
Congenital Blood Coagulation Factor XIII Deficiency and Perinatal Management
Current Drug Targets, Vol. 6, Iss. 5, 2005-08 ,pp. :
Synthetic and recombinant antithrombin drugs
By Kaiser B. Callas D. Walenga J.M. Fareed J.
Expert Opinion on Investigational Drugs, Vol. 7, Iss. 6, 1998-06 ,pp. :
Antithrombin III: no benefit in severe sepsis
Inpharma, Vol. 1, Iss. 1311, 2001-01 ,pp. :